Both in Pharmaceuticals
Gain Therapeutics vs Actinium Pharmaceuticals
Over the past year GANX returned −38.6% and ATNM returned +7.2%; their daily moves had a correlation of 0.19.
GANX −38.6% ATNM +7.2%Growth of $1, one year, split-adjusted
| Metric | GANX | ATNM |
|---|---|---|
| Price | $1.13 | $1.48 |
| Market cap | $49.3M | $46.5M |
| Today | −5.04% | −3.27% |
| 1 month | −34.3% | +28.7% |
| 6 months | −39.9% | +31.0% |
| Year to date | −64.9% | +8.8% |
| 1 year | −37.9% | +1.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | 79.7% |
| P/E (TTM) | — | 4.1× |
| Price / sales | — | 1.3× |
| Net cash | $12.7M | $36.5M |
| Dividend yield | — | — |
| Volatility (60d) | 64.4% | 90.4% |
| Short % of float | 7.6% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).